Back
CorMedix, Inc. 10K Form
Sell
27
CRMD
CorMedix, Inc.
Last Price:
$6.55
Seasonality Move:
-8.46%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-14 | 10Q | CRMD/CorMedix, Inc. Quarterly |
| 2023-08-08 | 10Q | CRMD/CorMedix, Inc. Quarterly |
| 2023-05-15 | 10Q | CRMD/CorMedix, Inc. Quarterly |
| 2022-11-10 | 10Q | CRMD/CorMedix, Inc. Quarterly |
| 2022-08-11 | 10Q | CRMD/CorMedix, Inc. Quarterly |
| 2022-05-12 | 10Q | CRMD/CorMedix, Inc. Quarterly |
Receive CRMD News And Ratings
See the #1 stock for the next 7 days that we like better than CRMD
CRMD Financial Statistics
Sales & Book Value
| Annual Sales: | $311.7M |
|---|---|
| Cash Flow: | $92.7M |
| Price / Cash Flow: | 3 |
| Annual Sales: | $5.11 |
| Price / Book: | 1.26 |
Profitability
| EPS (TTM): | 1.98350 |
|---|---|
| Net Income (TTM): | $163.1M |
| Gross Margin: | $275.7M |
| Return on Equity: | 67.96% |
| Return on Assets: | 37.93% |
CorMedix, Inc. Earnings Forecast
Key CorMedix, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for CRMD is 88.46%.
-
The Selling, General & Administrative Expenses for CRMD have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 6.20% of Revenue.
-
The Interest Expense is 1.71% of Operating Income.
-
The Net Earning history of CRMD is 52.31% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 11 years.
CorMedix, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CRMD |
| CUSIP: | 21900C |
| Website: | cormedix.com |
Debt
| Debt-to-Equity Ratio: | 0.37 |
|---|---|
| Current Ratio: | 2.11 |
| Quick Ratio: | 1.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 3.18 |
|---|---|
| Forward P/E Ratio: | 8.84 |
CRMD Technical Analysis vs Fundamental Analysis
Sell
27
CorMedix, Inc. (CRMD)
is a Sell
Is CorMedix, Inc. a Buy or a Sell?
-
CorMedix, Inc. stock is rated a SellThe current CorMedix, Inc. [CRMD] share price is $6.45. The Score for CRMD is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.